Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Oct 3;369(14):1379-80.
doi: 10.1056/NEJMc1308826.

Eculizumab in atypical hemolytic-uremic syndrome

Christophe M Legendre, Christoph Licht, Chantal Loirat
Free article
Comment

Eculizumab in atypical hemolytic-uremic syndrome

Christophe M Legendre et al. N Engl J Med. .
Free article
No abstract available

PubMed Disclaimer

Comment on

  • Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Clinical Trial.
  • Eculizumab in atypical hemolytic-uremic syndrome.
    Ring T. Ring T. N Engl J Med. 2013 Oct 3;369(14):1377-8. doi: 10.1056/NEJMc1308826. N Engl J Med. 2013. PMID: 24088106 No abstract available.
  • Eculizumab in atypical hemolytic-uremic syndrome.
    Amadio A, Tejani AM. Amadio A, et al. N Engl J Med. 2013 Oct 3;369(14):1378. doi: 10.1056/NEJMc1308826. N Engl J Med. 2013. PMID: 24088107 No abstract available.
  • Eculizumab in atypical hemolytic-uremic syndrome.
    Kistler AD. Kistler AD. N Engl J Med. 2013 Oct 3;369(14):1378. doi: 10.1056/NEJMc1308826. N Engl J Med. 2013. PMID: 24088108 No abstract available.
  • Eculizumab in atypical hemolytic-uremic syndrome.
    Tanimoto T, Oshima Y, Kami M. Tanimoto T, et al. N Engl J Med. 2013 Oct 3;369(14):1378-9. doi: 10.1056/NEJMc1308826. N Engl J Med. 2013. PMID: 24088109 No abstract available.

MeSH terms

Substances